共 50 条
- [41] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical TrialTARGETED ONCOLOGY, 2019, 14 (05) : 541 - 550Mokdad, Ali A.Zhu, HaoBeg, Muhammad S.Arriaga, YullDowell, Jonathan E.Singal, Amit G.Yopp, Adam C.
- [42] Evaluating the Efficacy and Safety of Silodosin on Nocturia in Patients With Benign Prostatic Hyperplasia: A Multicenter, Prospective, Open-label, Single-arm, Phase IV TrialUROLOGY, 2018, 121 : 153 - 157Cho, Kang JunLee, Jeong ZooSong, Yun SeobChoi, Jong BoKim, Dae KyungKim, Yong TaeKim, Joon Chul
- [43] An open-label, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-lightening agent in Filipino womenINTERNATIONAL JOURNAL OF DERMATOLOGY, 2016, 55 (02) : 153 - 157Handog, Evangeline B.Datuin, Maria Suzanne L.Singzon, Ivan A.
- [44] Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trialINTERNATIONAL JOURNAL OF STD & AIDS, 2019, 30 (12) : 1156 - 1162Pellegrino, DanielaGryschek, RonaldoPenalva de Oliveira, Augusto CesarMarcusso, RosaCorreia, AdemirVidal, Jose E.
- [45] A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)BLOOD, 2020, 136Zhang, FengkuiPeng, GuangxinHe, GuangshengChang, HongGao, SujunLiu, XinjianChen, TongLi, PeiHan, BingMiao, MiaoGe, ZhengGe, XiaoyanLi, FeiLi, YingmeiWang, ShunqingWang, YiShen, YaqiTai, YanfeiZhang, TaoZhu, BoZou, Jianjun
- [46] Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trialBMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):Yang, DaweiJu, MinjieWang, HaoJia, YichenWang, XiaodanFang, HaoFan, Jia
- [47] Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trialBMC Pharmacology and Toxicology, 24Dawei YangMinjie JuHao WangYichen JiaXiaodan WangHao FangJia Fan
- [48] Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trialLANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (03): : 219 - 229Marron, Thomas U.Fiel, Maria IsabelHamon, PaulineFiaschi, NathalieKim, EdwardWard, Stephen C.Zhao, ZhenKim, JoelKennedy, PaulGunasekaran, GaneshTabrizian, ParissaDoroshow, DeborahLegg, MeredithHammad, AshleyMagen, AssafKamphorst, Alice O.Shareef, MuhammedGupta, Namita T.Deering, RaquelWang, WeiWang, FangThanigaimani, PradeepMani, JayakumarTroncoso, LeannaTabachnikova, AlexandraChang, ChristieAkturk, GurayBuckup, MarkHamel, StevenIoannou, GiorgioHennequin, ClotildeJamal, HajraBrown, HaleyBonaccorso, AntoinetteLabow, DanielSarpel, UmutRosenbloom, TaliaSung, Max W.Kou, BaijunLi, SiyuJankovic, VladimirJames, NicolaHam, Sara C.Cheung, Hung KamSims, Jennifer S.Miller, ElizabethBhardwaj, NinaThurston, GavinLowy, IsraelGnjatic, Sacha
- [49] Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trialLANCET ONCOLOGY, 2020, 21 (11): : 1433 - 1442Morschhauser, FranckTilly, HerveChaidos, AristeidisMcKay, PamelaPhillips, TycelAssouline, SaritBatievi, Connie LeeCampbell, PhillipRibrag, VincentDamaj, Gandhi LaurentDickinson, MichaelJurczak, WojciechKazmierczak, MaciejOpat, StephenRadford, JohnSchmitt, AnnaYang, JayWhalen, JenniferAgarwal, ShefaliAdib, DeyaaSalles, Gilles
- [50] Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trialEUROPEAN JOURNAL OF CANCER, 2023, 182 : 57 - 65Wang, XuanWu, XiaowenYang, YueXu, WeiranTian, HuiLian, BinChi, ZhihongSi, LuSheng, XinanKong, YanZhou, LiMao, LiliLi, SimingTang, BixiaYan, XieqiaoBai, XueGuo, JunCui, ChuanLiang